MADISON, Wis. - Exact Sciences Corp. (NASDAQ:EXAS), a leader in cancer screening and diagnostic tests with a market capitalization of $10 billion, announced clinical validation data for its ...
Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, shared clinical validation data for its OncodetectTM MRD test at the 2025 American Society of Clinical Oncology ...
A Houston mother was diagnosed with stage 4 colon cancer in 2021 after brushing off five subtle symptoms. Since then, she’s been raising awareness on TikTok.